:: Class Utilisation Summary 2010
See LEGEND for key to shading and symbols.
:: Subject Area - PHAR Term - Semester 1
PHAR3102 | PHAR3251 | PHAR4258 | PHAR4264 | PHAR9101 | PHAR9102 |
PHAR9107 | PHAR9111 | PHAR9114 | PHAR9118 | PHAR9121 | PHAR9127 |
Data is correct as at Mon Oct 11 02:00:30 EST 2010
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHAR3102 | Molecular Pharmacology | ||||||
LAB | H09A | 7721 | Enr | Full | 60/60 | 100% | Thu 09-12 (w2-5,6-11, Wurth 204) |
LEC | A | 7720 | Rel | Full | 60/60 | 100% | Mon 13 (w1-5,6-12, WurthLG02); Wed 09 (w1-5,6-12, WurthLG03) |
TUT | H13A | 7722 | Rel | Open | 28/30 | 93% | Thu 13 (w2-5,6-13, WurthLG03) |
TUT | H14A | 7723 | Rel | Full | 32/30 | > 100% | Thu 14 (w2-5,6-13, WurthLG03) |
PHAR3251 | Clinical & Exp'l Pharmacology | ||||||
LAB | M15A | 4149 | Enr | Open | 39/40 | 98% | Mon 15-18/even (w2,4,6,8,10,12, Wurth 204) |
LAB | M15B | 4150 | Enr | Open | 29/40 | 73% | Mon 15-18/odd (Wurth 204) |
LEC | A | 4148 | Rel | Open | 68/80 | 85% | Wed 12 (w1-5,6-12, Biomed ThB); Fri 12 (w1-5,6-12, Biomed ThB) |
TUT | H15A | 4151 | Rel | Open | 68/80 | 85% | Thu 15-17 (w2-5,6-13, Biomed ThF) |
PHAR4258 | Pharmacology Honours Full-Time | ||||||
HON | 01 | 9938 | Enr | Open* | 11/30 | 37% | |
PHAR4264 | Pharmacology Honours Part-Time | ||||||
HON | 01 | 9939 | Enr | Open* | 3/30 | 10% | |
PHAR9101 | Principles of Drug Action | ||||||
LEC | 001 | 9866 | Enr | Open | 22/40 | 55% | |
PHAR9102 | Pharm. Develp of New Medicines | ||||||
LEC | 001 | 9867 | Enr | Open | 25/30 | 83% | |
PHAR9107 | Therapeutics & Molec Basis of | ||||||
LEC | 001 | 9869 | Enr | Open | 18/30 | 60% | |
PHAR9111 | Pharmaceutical Formulation 2 | ||||||
LEC | 002 | 9874 | Enr | Open | 6/30 | 20% | |
PHAR9114 | Pharmacoeconomics | ||||||
LEC | 001 | 9870 | Enr | Open | 10/30 | 33% | |
PHAR9118 | Therap&Molec Basis of Disease2 | ||||||
LEC | 002 | 9873 | Enr | Open | 15/30 | 50% | |
PHAR9121 | Postmarketing Development Med | ||||||
LEC | 002 | 9872 | Enr | Open | 25/30 | 83% | |
PHAR9127 | Safety and Efficacy | ||||||
OTH | 002 | 9871 | Enr | Open | 23/40 | 58% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |